Pfizer could have working Covid-19 vaccine before the end of 2020

Pfizer should know if COVID vaccine works by end of October

Covid-19 vaccine: Pfizer, BioNTech to expand Phase 3 trials, expect results by October

Over 12,000 study participants had received a second dose of the vaccine, Pfizer executives said on an investor conference call.

A committee of outside experts - with knowledge of which individuals were given vaccine shots, is also reviewing safety data on a weekly basis and are "not notified of any safety concerns to date", Kathrin Jansen, Pfizer's head of vaccine research said during the meet.

There are now nine vaccine candidates in late-stage human trials, although some have hit recent obstacles - pharma giant AstraZeneca and Oxford University momentarily paused clinical trials last week after a volunteer developed an unexplained illness.

Depay au Barça ? La réponse cash d'Aulas — Mercato
C'est ce qu'annonçait le journal néerlandais Telegraaf tard hier soir . Mais ce n'est pas le même son de cloche du côté lyonnais.


He did not say how many people had dropped out.

In India, Serum Institute is conducting Phase 2/3 human trials for the COVID-19 vaccine developed by the University of Oxford and AstraZeneca.

AstraZeneca announced that the centres were recruiting up to 30,000 participants for the third phase trials in the United States.

Benzema inscrit un quadruplé lors du carton du Real face à Getafe
Une rencontre d'entraînement qui s'est soldée sur le score de 6-0 en faveur des hommes de Zinedine Zidane. Le Real Madrid a disputé un match amical face à Getafe, ce mardi.


Trials are also being carried out in the Netherlands and Germany, taking the total number of participants in all three countries to 550.

Registered before the full set of three trial phases, the process of the vaccine's creation has been criticized by many scientists overseas for its rapid pace of production and improper testing. Borobia said phase two was scheduled to run for 14-16 months. "With this arrangement, we have now put in place a global supply chain that includes the recently acquired Praha Vaccines and partnerships with leading biologics manufacturers, enabling production on three continents", Novavax CEO Stanley Erck said in a statement. "And that's our primary responsibility, the safety of the American people". In August, Russia's Minister of Trade and Industry Denis Manturov claimed that the country would produce a thousand doses of vaccine per month before the end of the year.

As pharmaceutical companies in the USA and around the world work with government agencies to build a reliable timeline toward offering the world a viable vaccine, we seem to be in a hypothetical tug-o-war, with President Trump's administration pulling the date back to sometime this year, and other experts - some scientific, some private - arguing for more time.

South Dakota AG involved in fatal crash, reported he hit a deer
He called police and informed them that he had struck something, a spokesperson for Ravnsborg told the New York Times . He said the pair got out of the vehicle and searched for what they thought was a deer, according to the letter.


Latest News